Review
doi: 10.1016/0954-6111(93)90128-m.
New developments in the treatment of asthma and chronic obstructive pulmonary disease
Affiliations
- PMID: 7901879
- DOI: 10.1016/0954-6111(93)90128-m
Item in Clipboard
Review
New developments in the treatment of asthma and chronic obstructive pulmonary disease
Respir Med.
1993 Aug.
No abstract available
Similar articles
-
[Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].Verh Dtsch Ges Inn Med. 1988;94:364-75. Verh Dtsch Ges Inn Med. 1988. PMID: 2905102 Review. German. No abstract available.
-
Long-term treatment in asthma and COPD.Eur Respir J. 1990 Oct;3(9):1089-91. Eur Respir J. 1990. PMID: 1981192 No abstract available.
-
[New directions in pharmacotherapy for bronchial asthma].Pol Tyg Lek. 1993 Feb 15-22;48(7-8):181-7. Pol Tyg Lek. 1993. PMID: 8105454 Review. Polish. No abstract available.
-
[The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].Ned Tijdschr Geneeskd. 1999 Jan 16;143(3):137-40. Ned Tijdschr Geneeskd. 1999. PMID: 10086126 Review. Dutch.
-
Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies.Arch Intern Med. 1993 Apr 12;153(7):814-28. Arch Intern Med. 1993. PMID: 8096690 Review.
Cited by
-
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD001104. doi: 10.1002/14651858.CD001104.pub2. Cochrane Database Syst Rev. 2006. PMID: 16855959 Free PMC article.
-
Pharmacokinetic optimisation of asthma treatment.Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006. Clin Pharmacokinet. 1994. PMID: 7914480 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
